Long-Term Survival in 1,931 Patients With Dizziness: Disease- and Symptom-Specific Mortality by Berge, Jan Erik et al.
Long-Term Survival in 1,931 Patients With Dizziness:
Disease- and Symptom-Specific Mortality
Jan Erik Berge, MD ; Stein Helge Glad Nordahl, MD, PhD; Hans Jørgen Aarstad, MD, PhD ;
Frederik Kragerud Goplen, MD, PhD
Objective: To evaluate mortality among patients referred for suspected vestibular disorder and to examine whether spe-
cific symptoms or disorders predict long-term survival among patients with dizziness or vertigo.
Study Design: Retrospective cohort study.
Methods: This retrospective cohort study analyzed long-term survival data. Consecutive patients examined for suspected
vestibular disease at an otolaryngology clinic completed a detailed questionnaire regarding symptoms and comorbidities.
Results: The study included 1,931 patients. Their mean age (standard deviation) was 50.5 (16.5) years, and 60% were
women. The mean follow-up period was 20.6 years (range, 15.3–27.5 years). The standardized mortality ratio for the entire
cohort compared with the Norwegian age- and sex-matched population was 1.03 (95% confidence interval [CI]: 0.94–1.12),
illustrating no difference in overall survival. Patients with a cerebrovascular cause of dizziness had higher mortality in adjusted
Cox regression analyses (hazard ratio [HR] 1.56, 95% CI: 1.11–2.19), whereas patients reporting periodic or short attacks of
dizziness had lower mortality (HR 0.62 [0.50–0.77] and 0.76 [0.63–0.93], respectively). Reported unsteadiness between dizzi-
ness attacks was associated with higher mortality with an HR of 1.30 (95% CI: 1.08–1.57).
Conclusion: This long-term study found comparable mortality rates between patients evaluated for suspected vestibular
disorder and that of the general population. However, subgroup analyses showed reduced mortality in patients with periodic
or short attacks of dizziness and increased mortality in patients with unsteadiness between attacks or cerebrovascular causes
of dizziness. The time course of vestibular symptoms should be determined, and thorough evaluation including fall risk and
comorbidities must be considered in patients with nonepisodic symptoms.
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INTRODUCTION
Vestibular symptoms include dizziness, vertigo,
vestibulovisual symptoms, and unsteadiness.1 The US
National Health Interview Survey (NHIS) indicated that
23.8 million adult Americans (11.1%) had reported dizzi-
ness or balance problems during the last 12 months.2
Those experiencing these symptoms had a twofold higher
mortality rate (relative risk, 2.2; 95% confidence interval
[CI], 1.8–2.8), a risk comparable to that of other leading
causes of death such as diabetes mellitus, cardiovascular
disease, and cancer.2 It is less likely that the patient will
be referred to clinics specializing in vestibular disorders if
the referring physician finds other serious underlying dis-
ease to be the most likely cause of the patient’s symptoms.
However, the predictors of long-term survival have not
been examined in patients with dizziness seen in otolaryn-
gology or neurotology clinics. To what extent vestibular
disorders such as Ménière’s disease and benign paroxys-
mal positional vertigo (BPPV) are associated with survival
is unknown; furthermore, whether specific vestibular
symptoms such as unsteadiness or spinning vertigo are
relevant for survival has also not been elucidated.
Although patient history is essential when diagnosing
patients with dizziness, the diagnostic yield and prognostic
value of various patient-reported symptoms remain uncer-
tain. Differentiation based on the type of dizziness was pre-
viously advocated, and spinning vertigo was considered a
typical feature of benign, peripheral vestibular disor-
ders.3,4 Van Vugt et al. reported lower mortality among
older patients in primary care settings with vertigo com-
pared with the mortality in those with presyncope, disequi-
librium, or other types of dizziness.5 However, patients are
inconsistent when describing the types of dizziness they
have experienced,6 and differentiation based on the
reported type of dizziness has been criticized.4 An alterna-
tive differentiation is based on the time course and triggers
of dizziness,7,8 and categorization of acute, episodic, and
chronic vestibular syndromes is included in the World
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Health Organization International Classification of Dis-
eases (ICD-11).9 The risk of falls increases with increasing
numbers of patient-reported vestibular symptoms, and
self-reported unsteadiness has been shown to predict falls
and disability after 2 years.10,11 These findings correspond
well with several studies reporting that impaired balance
in physical testing was associated with reduced survival in
middle-aged and older persons.12–14 Thus, as dizziness and
balance problems are associated with a dramatic increase
in mortality in the general population, it is also important
to investigate this association in the otolaryngology set-
ting. Furthermore, the identification of specific findings in
the history or specific diagnoses that predict increased
death risk is also important as such information could lead
to individualized follow-up.
The present study aimed to evaluate overall survival
among patients examined for dizziness in a tertiary oto-
laryngology clinic and to determine the survival predic-
tion of dizziness diagnoses and the details of patient
history such as dizziness type, symptom timing, and asso-
ciated symptoms.
MATERIALS AND METHODS
This cohort study included consecutive patients examined
between 1992 and 2004 at the vestibular and balance laboratory
at the Department of Otorhinolaryngology and Head and Neck
Surgery at Haukeland University Hospital, Norway. The clinic
serves as a tertiary care clinic for vestibular disorders and also
receives referrals from primary care physicians for patients with
suspected vestibular disease.
Before examination, the patients completed a questionnaire
containing questions on the symptom time course, dizziness
description, dizziness triggers, accompanying symptoms, and how
they felt between attacks of dizziness (not troubled, unsteady, or
other [free text]). The questionnaire also included questions on
previous and concurrent diseases, including diabetes mellitus and
cardiovascular disease. The categories were not mutually exclu-
sive, but for timing patients usually reported only one category. A
more detailed description of the questionnaire and responses in
various categories has been described in detail previously.15
The patients underwent laboratory testing including
videonystagmography or electronystagmography, bithermal calo-
ric testing, and audiometry.
The causes of dizziness were determined by an otolaryngol-
ogist after clinical examination. The inclusion of patients was
performed over 12 years, and there were some changes in the
diagnostic criteria over this period. To verify the accuracy of
diagnoses, all diagnoses were reviewed by two of the coauthors
(F.K.G. and S.H.G.N.) and categorized for the purpose of this study.
The study was approved by the Regional Committee for
Medical and Health Research Ethics (REK 2012-1075) with
requirement that patients still alive were informed of the study
by mail and provided an opportunity to withdraw. All patients
alive in 2016 were thus informed, and patients with unknown
address were excluded from the study.
Date of examination in the clinic was regarded as start of
observation time. Data on vital status and date of death if they
had died were retrieved from the Norwegian National Registry
on June 28, 2019; this represents the end of the observation
period. Patients where it could not be determined whether they
had died or were alive at this time were regarded as lost to
follow-up and were excluded from the study. Person-years at risk
were calculated from start of observation time until whichever
occurred first June 28, 2019, or death.
Kaplan-Meier curves were used to illustrate survival in
patients grouped by diagnoses and selected symptoms. Statistical
differences between survival curves were tested by log-rank tests.
The standardized mortality ratio (SMR) was calculated by
indirect standardization to compare mortality in the cohort with
the mortality of the general Norwegian population. The SMR
represents the relative mortality of the study population com-
pared with the expected mortality in a reference population. The
expected number of deaths was calculated as the total number of
person-years at risk for each sex-specific age group with 5-year
intervals multiplied by the corresponding death rate in the Nor-
wegian population for the same groups. The sex-specific age
group mortality was retrieved from Statistics Norway,16 and
mortality rates from 1999 were used as the reference mortality
rate as this was the middle year of inclusion in the study.
Cox proportional hazards regression models were used to
calculate crude and adjusted hazard ratios (HRs) for patient-
reported symptoms and known comorbidities (diabetes mellitus
and cardiovascular disease). HRs represent the ratio of probabil-
ity of death depending on predictor variables. In this study, we
report the HR between patients reporting specific symptoms
compared with patients not reporting that specific symptom. For-
ward Cox-regression analysis adjusted for age, sex, former car-
diovascular disease, and diabetes mellitus was performed to
create a final model with a significance level set at P < .05. The
assumptions of proportional hazards and specifications were
checked using graphical methods, link tests, and tests based on
Schonfeld residuals.
All statistical analyses were performed using Stata
(StataCorp. 2017. Stata: Release 15. Statistical Software;
StataCorp LLC, College Station, TX). Two-sided P-values < .05
were considered statistically significant.
RESULTS
Of the 2,058 patients with patient-reported symp-
toms of dizziness at baseline, 40 were lost to follow-up and
87 were missing consent; thus, this study included 1,931
patients. Of these, 1,154 (59.8%) were women and the
mean age at examination was 50.5 years (standard devia-
tion 16.5 years). The mean time interval from examination
in the clinic until the end of observation was 20.6 years
(range, 15.3–27.5 years). The most common vestibular
diagnosis was vestibular neuritis (252 patients, 13.1%)
followed by BPPV (235 patients, 12.2%), Ménière’s disease
(204 patients, 10.6%), and vestibular schwannoma
(76 patients, 3.9%). A total of 151 patients (7.8%) were
diagnosed with a cerebrovascular cause of dizziness with-
out concurrent vestibular disease, whereas 715 patients
(37.0%) were diagnosed with unspecified nonvestibular
causes of dizziness.
Mortality Compared With The General
Population
The 5- and 10-year mortality rates in the entire
cohort were 4.3% and 10.1%, respectively. The SMR was
1.03 (95% confidence interval [CI] 0.94–1.12) for the
entire cohort, illustrating no difference in mortality com-
pared with the expected mortality in the general Norwe-
gian population matched for age and sex. Patients who
reported periodic dizziness had a 17% lower mortality
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rate with an SMR of 0.83 (0.70–0.98) compared with the
age- and sex-matched general Norwegian population,
whereas patients reporting constant dizziness had bor-
derline significantly increased mortality with an SMR of
1.20 (1.00–1.43) compared with the age- and sex-matched
Norwegian population.
Predictive Values of Selected Symptoms of
Dizziness
Figure 1 shows the unadjusted Kaplan-Meier plots
of survival based on selected symptoms. Survival analysis
adjusted for age and sex (Table 1) showed the risk of mor-
tality to be 27% lower in patients reporting periods of diz-
ziness (HR 0.73, 95% CI: 0.60–0.89) compared with
patients who did not report this symptom. In contrast,
patients reporting constant dizziness had a 30% higher
risk of mortality (HR 1.30 [1.05–1.60]) compared with
patients who did not report constant dizziness. Patients
who reported spinning vertigo or dizziness triggered by
sound had a lower risk of mortality (HR 0.83 [0.69–0.99]
and 0.61 [0.40–0.93], respectively), whereas dizziness
triggered by medication was associated with a nearly two-
fold increase in risk of mortality (HR 1.85 [1.08–3.14]).
Cox regression analysis performed for each symptom
adjusted for age, sex, diabetes mellitus, and cardiovascu-
lar disease showed that periodic dizziness was associated
with a 30% lower risk of mortality (HR 0.70 [0.58–0.86]),
whereas constant dizziness was associated with a 25%
increased risk of mortality (HR 1.26 [1.01–1.55]). Spin-
ning vertigo and dizziness triggered by sound were associ-
ated with a reduced risk of mortality in analyses adjusted
for age, sex, and comorbidities (HR 0.80 [0.67–0.96] and
0.61 [0.39–0.93], respectively).
The results of stepwise Cox regression analysis of
patient-reported symptoms adjusted for age, sex, cardio-
vascular disease, and diabetes mellitus are presented in
Table 2. Among patient-reported symptoms, periodic or
short attacks of dizziness were associated with reduced
risk of mortality (HR 0.62 [0.50–0.77] and 0.76
[0.63–0.93], respectively). Unsteadiness between dizzi-
ness attacks was associated with increased risk of mortal-
ity (HR 1.30 [1.08–1.57]). Dizziness triggered by sound
was associated with decreased risk of mortality (HR 0.59
[0.38–0.91]). Analysis without adjustment for cardiovas-
cular disease and diabetes mellitus identified the same
significant predictors (data not shown).
Survival According to Diagnosis
Unadjusted Kaplan-Meier plots of survival according
to cause of dizziness are shown in Figure 2. Cox regres-
sion analysis adjusted for age, sex, and cause of dizziness
showed increased risk of mortality among patients with
cerebrovascular causes of dizziness 1.56 (1.11–2.19) com-
pared with that in patients with BPPV (Table 3).
Survival According to Symptom Categories
Patient reports of one or more triggers of dizziness
were associated with reduced risk of mortality in the
unadjusted analysis (HR 0.71 [0.60–0.86]) compared with
patients who did not report any triggers of dizziness. This
was, however, no longer significant after adjusting for age,
sex, and comorbidities (HR 0.83 [0.69–1.00]). After adding
the numbers of responses by the patients in the categories
of dizziness timing, dizziness type, associated symptoms,
and dizziness triggers, the total number of responses was
associated with reduced risk of mortality (HR 0.92
[0.89–0.95] in unadjusted analysis and 0.95 [0.92–0.99] in
analyses adjusted for age, sex, and comorbidities).
DISCUSSION
The main finding in this study was that patients
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Fig. 1. Kaplan-Meier unadjusted survival estimates by patient-reported symptoms in 1,931 patients with dizziness. *P-value from log-
rank test.
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vestibular disorder had a long-term overall mortality rate
similar to that of the general population after adjusting
for age and sex. However, we observed major differences
within the group, with reduced mortality among patients
with short attacks or periodically fluctuating dizziness
and increased mortality in patients with constant symp-
toms or unsteadiness between attacks.
Our main findings are consistent with those of a
Swedish population-based study that observed no
increased mortality in patients on sick leave or disability
TABLE I.
Cox Regression Analysis with Hazard Ratios of Survival for Various Patient-Reported Symptoms and Comorbidities among 1,931 Patients
with Dizziness.
Adjusted for Age and Sex
Adjusted for Age, Sex,
Diabetes Mellitus, and
Cardiovascular Disease
Number of Patients Reporting the





Other diseases Diabetes mellitus 49 (2.5%) 2.40 (1.80–3.38) <.001 2.37 (1.68–3.33) <.001
Cardiovascular
disease
156 (8.1%) 1.60 (1.27–2.00) <.001 1.58 (1.26–1.98) <.001
Dizziness timing Short attacks 874 (45.3) 0.85 (0.71–1.02) .081 0.87 (0.72–1.04) .131
Periods 706 (36.6) 0.73 (0.60–0.89) .002 0.70 (0.58–0.86) .001
Constant 399 (20.7) 1.30 (1.05–1.60) .014 1.26 (1.01–1.55) .033
Other, free text 7 (0.4) 2.65 (0.85–0.26) .093 2.30 (0.73–7.20) .154
Dizziness type Spinning 933 (48) 0.83 (0.69–0.99) .038 0.80 (0.67–0.96) .017
Rocking 596 (30.9) 1.08 (0.88–1.22) .453 1.06 (0.86–1.30) .577
Other, free text 401 (20.8) 1.07 (0.86–1.33) .529 1.03 (0.83–1.28) .799
Walking on pillows or
floating
375 (19.4) 0.80 (0.61–1.05) .113 0.82 (0.63–1.08) .165
Drop attacks/
vestibular falls
213 (11.0) 1.18 (0.89–1.56) .240 1.15 (0.87–1.51) .335
Accompanying
symptoms
Syncope 132 (6.8) 1.05 (0.74–1.49) .772 1.11 (0.78–1.58) .547
Headache 550 (28.5) 0.91 (0.74–1.12) .053 0.90 (0.73–1.11) .333
Nausea 1,049 (54.3) 0.89 (0.75–1.07) .205 0.86 (0.72–1.03) .109
Vomiting 507 (26.3) 0.96 (0.78–1.17) .676 0.95 (0.78–1.16) .633
Visual disturbances 560 (29.0) 0.96 (0.77–1.18) .673 0.92 (0.74–1.14) .452
Near-fainting 289 (15.0) 0.99 (0.76–1.28) .921 0.91 (0.70–1.19) .491
Other, free text 241 (12.5) 0.84 (0.61–1.15) .271 0.83 (0.61–1.14) .262
None 473 (24.5) 1.10 (0.91–1.35) .324 1.19 (0.97–1.45) .099
Tinnitus During dizziness
attacks
153 (7.9) 1.07 (0.77–1.50) .670 0.97 (0.69–1.36) .866
Independent of
dizziness attacks
543 (17.5) 0.89 (0.72–1.10) .276 0.90 (0.73–1.11) .329
Hearing loss During dizziness
attacks
93 (4.8) 1.14 (0.77–1.70) .512 1.18 (0.79–1.76) .411
Independent of
dizziness attacks
338 (17.5) 0.96 (0.77–1.20) .715 0.96 (0.76–1.20) .696
Dizziness triggers Positional change 678 (35.1) 1.03 (0.85–1.24) .789 1.00 (0.83–1.20) .964
Sleep deprivation 278 (14.4) 0.87 (0.61–1.24) .440 0.86 (0.60–1.23) .408
Neck movements 555 (28.7) 0.93 (0.76–1.14) .474 0.39 (0.75–1.12) .392
Light or darkness 138 (7.1) 0.94 (0.60–1.45) .764 0.88 (0.57–1.38) .579
Sound 204 (10.6) 0.61 (0.40–0.93) .022 0.61 (0.39–0.93) .022
Psychological factors 115 (6.0) 1.03 (0.67–1.57) .909 0.93 (0.60–1.43) .728
Medication 35 (1.8) 1.85 (1.08–3.14) .024 1.64 (0.96–2.81) .071
Infection/fever 66 (3.4) 1.04 (0.54–2.02) .900 1.05 (0.54–2.05) .878
Other, free text 344 (17.8) 0.82 (0.63–1.08) .162 0.84 (0.64–1.11) .220
Unsteadiness
between attacks
687 (35.6) 1.20 (1.00–1.44) .050 1.19 (0.99–1.43) .060
†Hazard ratio represents the ratio of risk of mortality between patients reporting a specific symptom or disease compared with patients not reporting the
specific symptom or disease.
‡CI = confidence interval.
*P < .05 (bold text).
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pensions due to vestibular disorders17 but are not in line
with those in the NHIS study in which patients with diz-
ziness or balance problems had twofold increased
mortality.2 Other studies have reported increased risks of
stroke and vascular events among emergency department
patients with dizziness18–20 and hypertensive patients
with recurrent vertigo.21 However, our present cohort
comprised mainly outpatients referred to an ENT clinic
due to suspected vestibular disorder. We, therefore, infer
that our patients had been screened by the referring phy-
sicians for major nonvestibular causes, such as evident
cardiovascular or cerebrovascular disorder, and were usu-
ally not referred in cases of severe comorbidity or an obvi-
ous nonvestibular cause of their vestibular symptoms.
The findings in the present study should not be
directly generalized to patients with dizziness in acute
or subacute setting. We found that patients with cere-
brovascular causes of dizziness had a higher risk of mor-
tality compared with patients with BPPV. This may not
be surprising as cerebrovascular causes includes ische-
mic and hemorrhagic strokes known to be among the
leading causes of death globally.22 We expect that
patients with cerebrovascular cause of dizziness are
overrepresented in emergency departments compared
with the otolaryngological outpatient clinic. In addition,
the increased mortality among patients with dizziness in
emergency departments is most pronounced during the
TABLE II.
Cox Regression Analysis Adjusted for Age and Sex Including All Significant Variables for Survival with Hazard Ratios for Patient-Reported
Symptoms among 1,931 Patients with Dizziness.
Hazard Ratio† (95% CI‡) P-Value Stepwise Analysis§
Other diseases Diabetes mellitus 2.31 (1.64–3.26) <.001 1
Cardiovascular disease 1.66 (1.32–2.08) <.001 2
Timing of dizziness Periodic 0.62 (0.50–0.77) <.001 3
short attacks 0.76 (0.63–0.93) .006 4
Between attacks of dizziness Unsteady 1.30 (1.08–1.57) .005 5
Dizziness trigger Sound 0.59 (0.38–0.91) .017 6
The model for survival from forward Cox regression with a significance level of P < .05, adjusted for age, sex, self-reported symptoms, and comorbidities.
†Hazard ratio represents the ratio of risk of mortality between patients reporting a specific symptom or disease compared with patients not reporting the
specific symptom or disease.
‡CI, confidence interval.
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Fig. 2. Kaplan-Meier unadjusted survival estimates according to the
cause of dizziness in 1,931 patients.
TABLE III.
Cox Regression Analysis with Hazard Ratios of Survival for Various Causes for Dizziness among 1,931 Patients, Adjusted for Age, Sex, and
Cause of Dizziness.
Number of Patients (%) Hazard Ratio† (95% CI) P-Value*
Cause of dizziness
BPPV 235 (12) Reference
Vestibular neuritis 252 (12) 1.10 (0.77–1.57) .599
Ménière’s disease 204 (11) 0.89 (0.60–1.32) .566
Vestibular schwannoma 76 (4) 0.87 (0.51–1.48) .595
Other inner- or middle-ear disorder 67 (3) 1.29 (0.74–2.25) .365
Cerebrovascular 151 (8) 1.56 (1.11–2.19) .011
Other nonvestibular cause 715 (37) 1.05 (0.77–1.43) .744
Unknown or missing 231 (12) 1.18 (0.83–1.68) .352
†Hazard ratio represents the ratio of risk of mortality between patients with a specific diagnosis compared with patients with BPPV.
*P < .05 (bold text).
BPPV = benign paroxysmal positional vertigo; CI = confidence interval.
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first few months after discharge.18–20 The population in
our study comprised mainly patients with long-lasting
symptoms.
Patients who reported chronic dizziness and unstead-
iness showed increased risk of mortality. These patients
may be less socially and physically active due to vestibular
symptoms, with further negative consequences for their
health. Falls are also among the leading causes of injury
and death among older US citizens.23 Therefore, a causal
influence may exist between chronic vestibular symptoms
and mortality. In addition, chronic dizziness and unsteadi-
ness are associated with numerous medical, neurologic,
and cardiovascular disorders, many of which are linked to
increased mortality.
Reports of dizziness attacks or periodic fluctuations
were associated with better survival. This can be
explained by this time course being typical for benign ves-
tibular disorders such as BPPV, Ménière’s disease, and
vestibular migraine. These disorders were prevalent in
our study population. However, episodic dizziness can
also be associated with orthostatic hypotension, mass
lesions in the posterior fossa, and transient ischemic
attack.7 These findings indicate that the more serious
causes of episodic dizziness were outnumbered by benign
disorders in this cohort and that the episodic disorders
have better survival compared with patients reporting
chronic dizziness. Therefore, a differentiation between
episodic and chronic symptoms is clinically important as
this may represent two groups of patients with different
mortality.
Our findings strongly support the new categorization
of vestibular syndromes based on the time aspect of
symptoms, as suggested in the ICD-11 and the Interna-
tional Classification of Vestibular Disorders (ICVD).9,24
Most population-based studies combine dizziness and
unsteadiness. We recommend that future studies on ves-
tibular symptoms and mortality distinguish unsteadiness
from dizziness and vertigo.
Our analyses showed that triggered dizziness, par-
ticularly that triggered by sound, was associated with a
reduced risk of mortality compared with those patients
who did not report this symptom. Vertigo and dizziness
triggered by sound, that is, the Tullio phenomenon,25 are
distinct symptoms in the ICVD1 and are reportedly asso-
ciated with defects in the labyrinth, such as superior
semicircular dehiscence syndrome.26 However, in our
study, 10% of patients reported dizziness triggered by
sound, indicating this to be a less-specific finding that
should be confirmed by clinical examination and further
imaging and laboratory testing, as needed. Nevertheless,
patient-reported dizziness triggered by sound generally
represents benign conditions. The present study supports
former findings that patient-reported triggers of dizziness
should be confirmed by clinical testing.15
Although spinning vertigo was associated with
reduced risk of mortality after adjusting for age, sex, and
comorbidities, it failed to reach significance in the final
model (stepwise inclusion) when other symptom charac-
teristics, including timing, were included. Van Vugt and
colleagues found vertigo to be associated with a more
favorable outcome than other types of dizziness among
elderly patients in primary care,5 whereas Newman-
Toker and colleagues found that the type of dizziness was
inconsistently reported by patients in an emergency
department.6 Our findings indicated that the time course
of symptoms such as short attacks or episodic dizziness
was more relevant to survival than the quality of symp-
toms, such as spinning vertigo.
The main strength of this study was the very long
follow-up of a large cohort with well-documented vestibu-
lar diagnoses and patient-reported baseline data. The
results are especially relevant to clinics receiving refer-
rals due to chronic or episodic vestibular disorders, and
this study provides valuable clinical indicators of more
serious underlying disorders. We found that patients in
this cohort did not have a higher mortality rate than the
general population, but patients with episodic symptoms
had better survival compared with the other patients in
the cohort. A limitation of the study is that we did not
have data on cause of death or on falls. Such information
could have provided additional information on what cau-
ses the increased mortality among certain groups and
may determine if chronic dizziness were associated with
falls or if the increased mortality were associated with
other disorders such as cardiovascular disease. In addi-
tion, several commonly assigned diagnoses were not
included in the analyses as these were not defined by
diagnostic criteria when the study was designed, includ-
ing vestibular migraine and persistent postural-
perceptual dizziness.
CONCLUSION
In this long-term follow-up of patients with vestibu-
lar symptoms evaluated in an otolaryngology clinic, over-
all mortality was comparable with that in the general
population. However, periodic or short attacks of dizzi-
ness were associated with better survival, whereas
chronic dizziness and unsteadiness between attacks were
associated with increased mortality. These results under-
score the importance of classifying patients based on the
timing of symptoms. Patients reporting chronic symptoms
should be examined for specific risk factors and fall risk.
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